Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Out From Under Novartis, Alcon Is Its Own Company Now

Alcon is officially a standalone company. The eye care specialist officially spun out from Swiss pharma giant Novartis. Alcon began trading on the SIX Swiss Exchange and New York Stock Exchange under the symbol “ALC.”

Read More »

Alcon Spin-Off From Novartis: April 9, 2019

Novartis will officially spin its Alcon eye-care business off into a separately traded standalone business unit on April 9, 2019.

Read More »

Novartis 2019 growth outlook leaves investors wanting more

Novartis’ 2019 sales and profit guidance disappointed investors seeking more growth from the Swiss drugmaker.

Read More »

Novartis To Spin Off Alcon Eye Care Business

Switzerland-based Novartis announced plans to spin off Alcon, its eye care division, into a separately traded standalone company.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom